Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Employment agrmnt
Appointed director
Acq. announced
Quarterly results
Director departure
|
|
ChromaDex Corp. (CDXC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/23/2020 |
GN
| Cellular Health Market Leader Tru Niagen® Launches Online in Australia |
| 03/12/2020 |
GN
| ChromaDex Corrects Statements Made by an Unaffiliated Third Party Regarding its Product and COVID-19 |
| 03/10/2020 |
GN
| CHROMADEX CORPORATION REPORTS 2019 FINANCIAL RESULTS |
| 02/25/2020 |
GN
| ChromaDex to Report Fourth Quarter 2019 Financial Results on Tuesday, March 10, 2020 |
| 01/15/2020 |
GN
| ChromaDex Achieves New Regulatory Milestones in the European Union & Australia |
| 01/06/2020 |
GN
| First-of-its-Kind Clinical Study Initiated to Investigate Potential Benefits of Nicotinamide Riboside Combined with Exercise in Older Adults with Hypertension |
| 12/16/2019 |
GN
| ChromaDex Wins Nutritional Outlook's 2019 “Best of Industry” Ingredient Supplier Award for Niagen® |
| 12/05/2019 |
GN
| ChromaDex and Matakana Announce Expanded Retail Partnership in Australia & New Zealand |
| 12/02/2019 |
GN
| ChromaDex Receives Approval for Nicotinamide Riboside Chloride as an Ingredient for Complementary Medicines from the Australian Therapeutic Goods Administration (TGA) |
| 11/20/2019 |
GN
| European Commission Votes in Favor on Nicotinamide Riboside Chloride as a Novel Food |
| 11/12/2019 |
GN
| ChromaDex Corporation Reports Third Quarter 2019 Financial Results |
| 11/04/2019 |
GN
| ChromaDex to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019 |
| 10/31/2019 |
GN
| Tru Niagen® Wins ‘Most Favourite Brand' Award Among Watsons Hong Kong Loyalty Members |
| 10/11/2019 |
GN
| ChromaDex Statement Regarding the October 9th Order in the Central District of California Litigation |
| 09/26/2019 |
GN
| ChromaDex to Present at the 5th Annual B. Riley FBR Consumer and Media Conference |
| 08/14/2019 |
GN
| ChromaDex Announces $7 Million Private Placement of Common Stock |
| 08/06/2019 |
GN
| ChromaDex Adds Top Talent to its Leadership Team |
| 07/24/2019 |
GN
| TRU NIAGEN® Expands Canadian Retail Footprint with Distribution at Whole Foods Ontario Locations |
| 07/23/2019 |
GN
| ChromaDex Appoints Scripps Research Professor of Molecular Medicine, Brunie H. Felding, PhD, to the Scientific Advisory Board |
| 07/08/2019 |
GN
| Newly Published Nicotinamide Riboside Study Further Demonstrates Safety of Sustained Niagen Supplementation and Optimal Dosing Levels |
| 06/05/2019 |
GN
| TRU NIAGEN® Awarded ‘Ingredient of the Year: Healthy Aging' by NutraIngredients-USA |
| 05/09/2019 |
GN
| ChromaDex Corporation Reports First Quarter 2019 Financial Results |
| 04/24/2019 |
GN
| ChromaDex Furthers TRU NIAGEN® Global Expansion in Canada with WELL Health Technologies |
| 04/15/2019 |
GN
| ChromaDex Drives Global Expansion Strategy for TRU NIAGEN® with Specialty Retail Launch and Expanded eCommerce Distribution in Canada |
| 04/09/2019 |
GN
| New Study Deepens Research Into the Potential Cardiovascular Health Benefits of Supplementation with Nicotinamide Riboside (NR) |
| 04/03/2019 |
GN
| Dr. Charles Brenner, Discoverer of Nutrient Nicotinamide Riboside as a Vitamin, Announced as Speaker at Upgrade XP???s Sixth Annual Biohacking Conference |
| 04/01/2019 |
GN
| Consolidated Research: 2019 Summary Expectations for Vishay Intertechnology, Belmond, Silicon Motion Technology, Ardmore Shipping, Northwest Pipe, and ChromaDex — Fundamental Analysis, Key Performance Indications |
| 03/08/2019 |
GN
| ChromaDex Brings TRU NIAGEN® to SXSW® 2019 |
| 02/28/2019 |
GN
| ChromaDex to Report Fourth Quarter 2018 Financial Results on Thursday, March 7, 2019 |
| 01/23/2019 |
GN
| New Study Shows Supplementation with Nicotinamide Riboside (NR) During Breastfeeding Yields Measurable, Lasting Benefits to Mothers and Offspring in Animal Model |
| 01/22/2019 |
GN
| ChromaDex Prepared to Proceed with Patent Infringement Action Against Elysium Health |
| 12/20/2018 |
GN
| ChromaDex Corp. and Nestlé Health Science Enter Global Commercial License and Supply Agreement for TRU NIAGEN® |
| 12/17/2018 |
GN
| TRU NIAGEN® Expands North American Footprint with Product Launch in Canada |
| 12/12/2018 |
GN
| TRU NIAGEN® to be Featured at the American Academy of Anti-Aging Medicine Annual Meeting |
|
|
|